Background and Study Aims: Several endoscopic antireflux therapies have been marketed, but long-term data on
their objective and clinical efficacy are sparse. This report presents prospective
1-year follow-up results, including technical, clinical, and functional success rates,
for the first of these treatments to be developed, endoscopic gastroplication (EGP).Patients and Methods: A total of 43 EGP procedures were carried out in 38 patients with gastroesophageal
reflux disease (GERD). Two or three EndoCinch gastroplications were constructed at
the level of the gastric cardia in each patient; five patients were treated twice
within 6 - 12 months. Each endoscopic suture joined two gastric folds to each other
as a double fold, known as a ”gastroplication”, in order to narrow the esophagogastric
junction. Postprocedure data after 2 months and after 1 year were compared with preoperative
data, focusing on symptoms, medication requirements, endoscopic findings, and pH-metry
results.Results: In contrast to the findings at 2 months (which showed that 72 % of the sutures were
present and that there was a reduction in the percentage of time when the esophageal
pH was < 4 from 15.4 % to 8.7 %), the results 1 year after EGP were considered to
indicate failure of the treatment in all 38 patients because none of them still had
all of the initially placed gastroplications in situ (90 % of gastroplications were
lost). The percentage of patients who did not require proton pump inhibitor medication
decreased from 52 % at 2 months to only 20 % at 1 year and even more patients had
evidence of reflux esophagitis at 1 year (56 %) than had initially demonstrated signs
of this (41 %).Conclusions: EGP has some short-term beneficial effects on clinical symptoms and pH-metry. However,
mainly due to the loss of the endoscopically placed sutures, these effects were not
maintained at the 1-year follow-up. EGP cannot therefore be recommended for routine
clinical use. Better endoscopic methods need to be developed, and they should be adequately
tested before being marketed.
References
- 1
Galmiche J P, Bruley des Varannes S.
Endoluminal therapies for gastro-oesophageal reflux disease.
Lancet.
2003;
361
1119-1121
- 2
Triadafilopoulos G, DiBaise J K, Nostrant T T. et al .
The Stretta procedure for the treatment of GERD: 6- and 12-month follow-up of the
US open label trial.
Gastrointest Endosc.
2002;
55
149-156
- 3
Johnson D A, Ganz R, Aisenberg J. et al .
Endoscopic, deep mural implantation of Enteryx for the treatment of GERD: 6-month
follow-up of a multicenter trial.
Am J Gastroenterol.
2003;
98
250-258
- 4
Fockens P, Bruno M J, Gabbrielli A. et al .
Endoscopic augmentation of the lower esophageal sphincter for the treatment of gastroesophageal
reflux disease: a multicenter study of the gatekeeper reflux repair system.
Endoscopy.
2004;
36
682-689
- 5
Filipi C J, Lehman G A, Rothstein R I. et al .
Transoral, flexible endoscopic suturing for treatment of GERD: a multicenter trial.
Gastrointest Endosc.
2001;
53
416-422
- 6
Corley D A, Katz P, Wo J M. et al .
Improvement of gastroesophageal reflux symptoms after radiofrequency energy: a randomized,
sham-controlled trial.
Gastroenterology.
2003;
125
668-676
- 7
Swain P, Park P O, Mills T.
Bard EndoCinch: the device, the technique, and pre-clinical studies.
Gastrointest Endosc Clin N Am.
2003;
13
75-88
- 8
Mahmood Z, McMahon B P, Arfin Q. et al .
EndoCinch therapy for gastro-oesophageal reflux disease: a 1-year prospective follow-up.
Gut.
2003;
52
34-39
- 9
Velanovich V, Ben-Menachem T, Goel S.
Case-control comparison of endoscopic gastroplication with laparoscopic fundoplication
in the management of gastroesophageal reflux disease: early symptomatic outcomes.
Surg Laparosc Endosc Percutan Tech.
2002;
12
219-223
- 10
Chadalavada R, Lin E, Swafford V. et al .
Comparative results of endoluminal gastroplasty and laparoscopic antireflux surgery
for the treatment of GERD.
Surg Endosc.
2004;
18
261-265
- 11
Feitoza A B, Gostout C J, Rajan E. et al .
Understanding endoluminal gastroplications: a histopathologic analysis of intraluminal
suture plications.
Gastrointest Endosc.
2003;
57
868-876
- 12
Dai Q, Brasseur J G, Dimitriou J. et al .
2-D and 3-D endoluminal ultrasound localization of endoscopic plications with simultaneous
manometry (location of plications and depth of sutures) [abstract].
Gastroenterology.
2004;
126
AB496
- 13
Ponchon T, Boyer J, Grimaud J C. et al .
A prospective multicenter phase II study to evaluate the EndoCinch suturing system
for the treatment of GERD [abstract].
Gastrointest Endosc.
2004;
59
AB244
- 14
Zabel-Langhennig A, Schiefke I, Neumann S. et al .
Endoscopic gastroplication (EndoCinch) as an alternative option in treatment of GERD:
an 18-month follow-up [abstract].
Gastroenterology.
2004;
126
AB330
- 15
Schilling D, Kiesslich R, Galle P R, Riemann J F.
First experience with a new endoscopic suture device (ESD) for endoscopic, endoluminal
therapy of GERD [abstract].
Gastrointest Endosc.
2004;
59
AB246
1 contributed equally
H. Abou-Rebyeh, M. D.
Department of Hepatology and Gastroenterology, Charité Universitätsmedizin Berlin
Campus Virchow-Klinikum · Humboldt University · Augustenburger Platz 1 · 13353 Berlin
· Germany
Fax: +49-30-450-553-917
Email: hassan.abou-rebyeh@charite.de